LON:AGL - ANGLE Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 53.50 +1.00 (+1.90 %)
(As of 01/16/2019 04:00 PM ET)
Previous CloseGBX 52.50
Today's RangeGBX 50.56 - GBX 55
52-Week RangeGBX 32.27 - GBX 80
Volume230,779 shs
Average Volume106,228 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ANGLE plc, a medical diagnostic company, provides cancer diagnostics and foetal health products. Its lead product is Parsortix cell separation system, which captures very rare circulating tumor cells in cancer patient blood. ANGLE plc was founded in 2004 and is based in Guildford, the United Kingdom.

Receive AGL News and Ratings via Email

Sign-up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Laboratories & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone+44-1483-685830

Debt

Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Price / Cash FlowN/A
Price / BookN/A

Profitability

Net IncomeN/A
Net MarginsN/A
Return on AssetsN/A

Miscellaneous

Employees43
OptionableNot Optionable

ANGLE (LON:AGL) Frequently Asked Questions

What is ANGLE's stock symbol?

ANGLE trades on the London Stock Exchange (LON) under the ticker symbol "AGL."

What price target have analysts set for AGL?

0 brokerages have issued 1 year target prices for ANGLE's stock. Their forecasts range from GBX 110 to GBX 110. On average, they anticipate ANGLE's stock price to reach GBX 110 in the next twelve months. This suggests a possible upside of 105.6% from the stock's current price. View Analyst Price Targets for ANGLE.

Has ANGLE been receiving favorable news coverage?

Headlines about AGL stock have trended somewhat negative this week, according to InfoTrie Sentiment. The research firm rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. ANGLE earned a coverage optimism score of -1.2 on InfoTrie's scale. They also gave media stories about the company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an effect on the company's share price in the near future.

Who are some of ANGLE's key competitors?

Who are ANGLE's key executives?

ANGLE's management team includes the folowing people:
  • Mr. Andrew David William Newland, Founder, CEO & Exec. Director (Age 56)
  • Mr. Ian Francis Griffiths, CFO, Fin. Director, Company Sec. & Exec. Director (Age 53)
  • Dr. Daniel J. O'Shannessy, Chief Scientific Officer
  • Mr. Paul Smith, VP & Chief Exec. Officer of ANGLE Biosciences Inc
  • Mr. Martin Cooke, Director of Manufacturing & Regulatory Affairs (Age 49)

How do I buy shares of ANGLE?

Shares of AGL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is ANGLE's stock price today?

One share of AGL stock can currently be purchased for approximately GBX 53.50.

What is ANGLE's official website?

The official website for ANGLE is http://www.angleplc.com/.

How can I contact ANGLE?

ANGLE's mailing address is The Surrey Research Park 3 Frederick Sanger Road, GUILDFORD, GU2 7YD, United Kingdom. The company can be reached via phone at +44-1483-685830.


MarketBeat Community Rating for ANGLE (LON AGL)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  99 (Vote Outperform)
Underperform Votes:  164 (Vote Underperform)
Total Votes:  263
MarketBeat's community ratings are surveys of what our community members think about ANGLE and other stocks. Vote "Outperform" if you believe AGL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AGL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/16/2019 by MarketBeat.com Staff

Featured Article: Front-End Load

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel